Manicaland PrEP Uptake Through Interactive Counselling Trial
NCT ID: NCT03565575
Last Updated: 2023-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1055 participants
INTERVENTIONAL
2018-07-07
2021-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this trial is to evaluate the impact of an interactive tablet based counselling session correcting risk perception and addressing ambiguity around availability, usability and effectiveness of PrEP on PrEP uptake within 6 months in adolescent girls and young women (AGYW) aged 18-24 years.
Hypothesis:
Correcting misperceptions of risks of HIV infection and off-setting ambiguity effects about the availability, usability and efficacy of PrEP, through localized, interactive, tablet-based counselling, will increase uptake of PrEP in HIV-negative AGYW.
Study outcomes:
The primary outcomes for the study will be risk perception measured in a follow-up survey at 6 months and proportion of women taking up PrEP within 6 months measured with biomarkers of plasma antiretroviral (ARV) drug presence.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care
NCT04316715
MI-based PrEP Intervention
NCT03313765
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
NCT01769456
Standardized Patient Encounters to Improve PrEP Counseling for Adolescent Girls and Young Women in Kenya
NCT03875950
Friendship Bench Mental Health Intervention for Adolescent Girls and Young Women in South African PrEP Delivery Settings
NCT05664490
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary analysis:
A two-stage intention-to-treat (ITT) analysis of cluster level summaries will be used. The parameter of interest is the adjusted risk difference in primary and secondary outcomes.
In the first stage, Logistic regression will be used to adjust for confounding variables at the individual level. The model will be fitted using data from both trial arms. The regression model will include terms for the covariates of interest and pair but not trial arm. Adjustment variables will include age group (\<20, 20-24), highest level of education completed, marital status and baseline measures of outcomes. In the second stage, a formal statistical comparison for differences in observed versus expected uptake by arm will be conducted using a two-sided paired significance test with α=0.05.
Secondary analysis:
In secondary analysis, the complier average causal effect (CACE) will be estimated using an instrumental variables approach. The parameter of interest is the adjusted risk difference in primary and secondary outcomes.
Heterogeneity by age and baseline levels of risk and time preferences will also be estimated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interactive tablet-based quiz
Individuals participate in an interactive tablet-based risk perception and PrEP counselling information session.
Interactive tablet-based quiz
Intervention participants play an interactive tablet based quiz including the following information components:
1. Risks of HIV infection under different scenarios such as between two hypothetical individuals and with different behaviours.
2. Interactive counselling on key facts around PrEP, its usability and local availability
All individuals will have the option to sign up for contact by a nurse from the health clinic to discuss PrEP further and make an appointment for a visit. Participants will also be given a PrEP referral letter which they can present directly at one of the participating study clinics to begin PrEP. In two sites a community-led intervention will also be implemented to address social obstacles and to increase support from peers, families and social structures.
Control arm
No intervention will be administered to the control arm
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interactive tablet-based quiz
Intervention participants play an interactive tablet based quiz including the following information components:
1. Risks of HIV infection under different scenarios such as between two hypothetical individuals and with different behaviours.
2. Interactive counselling on key facts around PrEP, its usability and local availability
All individuals will have the option to sign up for contact by a nurse from the health clinic to discuss PrEP further and make an appointment for a visit. Participants will also be given a PrEP referral letter which they can present directly at one of the participating study clinics to begin PrEP. In two sites a community-led intervention will also be implemented to address social obstacles and to increase support from peers, families and social structures.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-24 years
Exclusion Criteria
* Self-reporting taking PrEP at baseline
18 Years
24 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biomedical Research and Training Institute, Zimbabwe
OTHER
University of Copenhagen
OTHER
London School of Economics and Political Science
OTHER
National Institute of Mental Health (NIMH)
NIH
Simon Gregson
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simon Gregson
Professor of Demography and Behavioural Science
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simon Gregson, PhD
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Manicaland Centre for Public Health Research
Bonda, Manicaland Province, Zimbabwe
Manicaland Centre for Public Health Research
Eastern Highlands, Manicaland Province, Zimbabwe
Manicaland Centre for Public Health Research
Hobhouse, Manicaland Province, Zimbabwe
Manicaland Centre for Public Health Research
Honde, Manicaland Province, Zimbabwe
Manicaland Centre for Public Health Research
Nyazura, Manicaland Province, Zimbabwe
Manicaland Centre for Public Health Research
Sakubva, Manicaland Province, Zimbabwe
Manicaland Centre for Public Health Research
Selbourne, Manicaland Province, Zimbabwe
Manicaland Centre for Public Health Research
Nyanga, , Zimbabwe
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Thomas R, Skovdal M, Galizzi MM, Schaefer R, Moorhouse L, Nyamukapa C, Maswera R, Mandizvidza P, Hallett TB, Gregson S. Improving risk perception and uptake of pre-exposure prophylaxis (PrEP) through interactive feedback-based counselling with and without community engagement in young women in Manicaland, East Zimbabwe: study protocol for a pilot randomized trial. Trials. 2019 Dec 2;20(1):668. doi: 10.1186/s13063-019-3791-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P67251_PrEP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.